Aktie 891725 TOWA PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Towa Pharmaceutical Co., Ltd.

Aktien

891725

JP3623150004

4553

Markt geschlossen - Japan Exchange
Andere Börsenplätze
 08:00:00 19.04.2024 		% 5 Tage % 1. Jan.
2’750 JPY -1.04% Intraday Chart für Towa Pharmaceutical Co., Ltd. -0.76% +16.92%
2023 Towa Pharmaceutical Co. Ltd. meldet Ergebnis für das am 31. März 2023 endende Geschäftsjahr CI
2022 Towa Pharmaceutical Co., Ltd. (TSE:4553) hat die Übernahme von Sunsho Pharmaceutical Co., Ltd. von Carlyle Japan Partners III, einem von The Carlyle Group Inc. verwalteten Fonds, abgeschlossen. (NasdaqGS:CG). CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Towa Pharmaceutical Completes Payment for Director Stock Compensation
VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors
Towa Pharmaceutical : FY2023(1st quarter) Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023(Based on Japanese GAAP) (375K/7P)
Towa Pharmaceutical : FY2023(1st quarter) Supplementary Material of Financial Results (1.03M/28P)
Towa Pharmaceutical : Notice of the 67th Ordinary General Meeting of Shareholders （176KB／10P）
Towa Pharmaceutical : FY2022 Supplementary Material of Financial Results (1.2M/42P)
Towa Pharmaceutical : FY2022(4th quarter) Summary of Consolidated Financial Results for the Year Ended March 31, 2023(Based on Japanese GAAP) (616K/10P)
Towa Pharmaceutical : 2023年3月期 決算短信〔日本基準〕（連結）
Towa Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
Chugai and Towa Launch Edirol Tablet for Osteoporosis Treatment
Towa Pharmaceutical Co., Ltd. completed the acquisition of Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG).
TOWA PHARMACEUTICAL : INTEGRATED REPORT 2021
Towa Pharmaceutical Co., Ltd. agreed to acquire Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG) for ¥47.7 billion.
Chugai - Towa Pharmaceutical Receives Approval for Authorized Generic Version of Chugai's Osteoporosis Agent Edirol
Protosera, Inc. announced that it expects to receive funding from Towa Pharmaceutical Co., Ltd.
Luye Pharma : Strikes Licensing Deal with Japan's Towa Pharma for Alzheimer's Disease Drug
Luye Pharma Switzerland AG and Towa Pharmaceutical Co., Ltd. Enters Strategic Collaboration to Develop and Commercialize Rivastigmine Multi-Day Transdermal Patch in Japan
Towa Pharmaceutical : Breckenridge Pharmaceutical, Inc. - Towa completes acquisition of Esteve's Generic Division
Towa Pharmaceutical Co., Ltd. completed the acquisition of Pensa Investments S.L. from Esteve Pharmaceuticals, S.A.
Innophys Co., Ltd. announced that it has received ¥3.53 billion in funding from a group of investors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 891725 Aktie
  4. Nachrichten Towa Pharmaceutical Co., Ltd.
  5. Andere Sprachen